Načítá se...
Clusterin as a Potential Biomarker of Obesity-Related Alzheimer’s Disease Risk
Over 35% of the adult US population is obese. In turn, excess adiposity increases the risk of multiple complications including type 2 diabetes (T2D), insulin resistance, and cardiovascular disease; yet, obesity also independently heightens risk of Alzheimer’s Disease (AD), even after adjusting for o...
Uloženo v:
| Vydáno v: | Biomark Insights |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7555556/ https://ncbi.nlm.nih.gov/pubmed/33110346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1177271920964108 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|